---
figid: PMC6676405__ol-18-03-3399-g01
figtitle: Putative Cripto-1 targets the MAPK, FA and ErbB signalling pathways
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6676405
filename: ol-18-03-3399-g01.jpg
figlink: /pmc/articles/PMC6676405/figure/f2-ol-0-0-10626/
number: F2
caption: Putative Cripto-1 targets the MAPK, FA and ErbB signalling pathways. Solid
  arrows and boxes represent the data observed in U87-Cr1 cells confirmed from the
  literature, while dotted arrows and boxes represent data based on Kyoto Encyclopedia
  of Genes and Genomes pathway analysis but it is not known if Cripto-1 signals through
  these cascades or directly regulate these putative targets. Cripto-1 phosphorylates
  EGFR (Ser1070) or FGFR1 (Tyr654) which may be a part of the MAPK signalling pathway
  mediating cellular proliferation. In the FA pathway, Cripto-1 may regulate cell
  motility and invasion through binding ITGA, mediating the activation of the Src
  signalling cascade (Tyr418), FAK (Tyr396) and PXN (Tyr118). In addition, Cripto-1
  may signal, through the same binding, to control cellular survival through Src (Tyr418),
  FAK (Tyr396), p130CAS (Tyr410) and Bcl2 (Thr69) or to regulate cellular proliferation
  through Src (Tyr418), FAK (Tyr396), p130CAS (Tyr410) c-Jun (Ser63). This representative
  figure shows that Cripto-1 may signal through the ErbB signalling pathway to control
  cell migration, invasion and adhesion or angiogenesis via the signalling cascade
  ErbB1 (EFGR)(Ser1070)/ErbB2 (Her2)(Tyr877), Src (Tyr418), and FAK (Tyr396) or ErbB1
  (EFGR)(Ser1070)/ErbB2 (Her2)(Tyr877), c-Jun (Ser63), respectively. MAPK, mitogen-activated
  protein kinase; FA, focal adhesion; EGFR, epithelial growth factor receptor; FGFR,
  fibroblast growth factor receptor; ITGA, integrin a subunit; FAK, focal adhesion
  kinase; PXN, Paxillin.
papertitle: Cripto-1 overexpression in U87 glioblastoma cells activates MAPK, focal
  adhesion and ErbB pathways.
reftext: Faisal Alowaidi, et al. Oncol Lett. 2019 Sep;18(3):3399-3406.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8546834
figid_alias: PMC6676405__F2
figtype: Figure
redirect_from: /figures/PMC6676405__F2
ndex: 0d7e096c-df21-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6676405__ol-18-03-3399-g01.html
  '@type': Dataset
  description: Putative Cripto-1 targets the MAPK, FA and ErbB signalling pathways.
    Solid arrows and boxes represent the data observed in U87-Cr1 cells confirmed
    from the literature, while dotted arrows and boxes represent data based on Kyoto
    Encyclopedia of Genes and Genomes pathway analysis but it is not known if Cripto-1
    signals through these cascades or directly regulate these putative targets. Cripto-1
    phosphorylates EGFR (Ser1070) or FGFR1 (Tyr654) which may be a part of the MAPK
    signalling pathway mediating cellular proliferation. In the FA pathway, Cripto-1
    may regulate cell motility and invasion through binding ITGA, mediating the activation
    of the Src signalling cascade (Tyr418), FAK (Tyr396) and PXN (Tyr118). In addition,
    Cripto-1 may signal, through the same binding, to control cellular survival through
    Src (Tyr418), FAK (Tyr396), p130CAS (Tyr410) and Bcl2 (Thr69) or to regulate cellular
    proliferation through Src (Tyr418), FAK (Tyr396), p130CAS (Tyr410) c-Jun (Ser63).
    This representative figure shows that Cripto-1 may signal through the ErbB signalling
    pathway to control cell migration, invasion and adhesion or angiogenesis via the
    signalling cascade ErbB1 (EFGR)(Ser1070)/ErbB2 (Her2)(Tyr877), Src (Tyr418), and
    FAK (Tyr396) or ErbB1 (EFGR)(Ser1070)/ErbB2 (Her2)(Tyr877), c-Jun (Ser63), respectively.
    MAPK, mitogen-activated protein kinase; FA, focal adhesion; EGFR, epithelial growth
    factor receptor; FGFR, fibroblast growth factor receptor; ITGA, integrin a subunit;
    FAK, focal adhesion kinase; PXN, Paxillin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nplp1
  - btl
  - Egfr
  - Src42A
  - Csk
  - Src64B
  - Fak
  - dock
  - Nckx30C
  - Pxn
  - Pax
  - p130CAS
  - Pak
  - mbt
  - Crk
  - .na.character
  - bsk
  - Jra
  - Rap1
  - CycD
  - Debcl
  - Erk7
  - rl
  - MKP-4
  - p38b
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Dsor1
  - Mtk
  - EGFR
  - ERBB2
  - ERBB3
  - ERBB4
  - FGFR1
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - SRC
  - FGR
  - FYN
  - YES1
  - PTK2
  - NCK1
  - PXN
  - PXDN
  - BCAR1
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - CRK
  - MAPK8
  - MAPK9
  - MAPK10
  - JUN
  - RAPGEF1
  - RASGRF2
  - BRAF
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - CCND1
  - CCND2
  - CCND3
  - BCL2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - Ser1070
  - Tyr877
  - Ser
  - Thr
  - Cancer
---
